ArticleNeurochemical research2013

PARP-1 inhibitors DPQ and PJ-34 negatively modulate proinflammatory commitment of human glioblastoma cells.

Marina Scalia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.